[Photo] Price of Samsung BioLogics stock skyrockets at trade resumes
|
Posted on : Dec.11,2018 17:27 KST
Following the Korea Exchange’s decision to lift the suspension on trading Samsung BioLogics shares on the KOSPI listing, prices for the company’s shares have risen. Sales resumed on Dec. 11 at a price of 398,500 won (US$352.66) per share, exhibiting a 19.13% increase from its trading price before the suspension. It also climbed back to its number five spot in South Korea’s market capitalization rankings.
© 2012 The Hankyoreh Media Company. All rights reserved.
No part of this material may be reproduced, stored in a retrieval system, or transmitted
in any form or by any means, electronic, mechanical, mimeographical, in recorded form or
otherwise for commercial use, without the permission of the Hankyoreh Media Company.